Cited by 69Virus-based gene therapy researchRNA Interference and Gene DeliveryCRISPR and Genetic Engineering

Sources of off-target expression from recombinase-dependent AAV vectors and mitigation with cross-over insensitive ATG-out vectors

Open access
Fischer, Kyle B., Collins, Hannah K., Callaway, Edward M.·2019·Proceedings of the National Academy of Sciences

Abstract

Significance: The widespread use of recombinase-dependent adeno-associated virus (AAV) for targeting transgene expression to specific neural populations has made it a fundamental tool for neural manipulation and circuit dissection. Despite this, the well-known but oft-ignored issue of unwanted recombinase-independent “leak” expression from common recombinase-dependent DIO and FLEX AAV designs impedes certain applications and confounds data. Herein we discover that the leak expression from these constructs is due to both low-level expression of the inverted transgene and homology-dependent recombination in bacteria during plasmid production. Using this knowledge, we create a Cre-dependent AAV design that greatly decreases leak expression. This development will improve cell-type-specific transgene targeting for a wide spectrum of tools dependent on precise cell-type-specific targeting.

Integrity signals

Registry

Crossref · 10.1073/pnas.1915974116

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

The citation lists haven’t been fetched yet

References 37 · Cited by 69

Authors
Fischer, K. B., Collins, H. K., & Callaway, E. M.
Affiliations
Salk Institute for Biological Studies (US)
Corresponding author
Callaway, Edward M.
Venue
Proceedings of the National Academy of Sciences
Published
2019-12-16
Volume
116
Issue
52
Pages
27001-27010
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2995394447
Cited by
69
References
37
Citations by year
2026: 6 · 2025: 12 · 2024: 11 · 2023: 11 · 2022: 10 · 2021: 12 · 2020: 7
FWCI
4.37
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Science Foundation (IOS-1707261)
  • HHS | NIH | National Eye Institute (EY022577)
  • HHS | NIH | National Institute of Mental Health (MH063912)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
Keywords
off-target expression, Cre recombinase, Flp recombinase, homologous recombination, transgenic mouse lines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review